Hexin Med

PharmaceuticalsSeries ASuzhou, China

Latest round

Series A

Last raised

Mar 2023

Total raised

$14M

Investors

4

About Hexin Med

Founded in 2020 and based in Suzhou, China, Hexin Med operates as a targeted drug provider, specializing in the development of targeted therapeutic integrated nucleotide drugs. The company's first product has received the Notice of Drug Clinical Trial from the State Drug Administration in June 2022. The company has developed core technologies for PET contrast agents and targeted radiotherapy. Hexin Med also provides medical solutions such as specific tumor diagnostic contrast agent development, integrated diagnostic and therapeutic drugs, and other targeted drugs. The main products include 68Ga-HX01, 68Ga, 177Lu dual-targeted therapeutic class 1 new drug and RDC drug. The company mainly generates revenue from the R&D of targeted therapeutic integrated nucleotide drugs.

Who invested in Hexin Med

4 investors across 2 rounds

See all investors in Hexin Med

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Mar 2, 2023

    Amount

    $14M

    Investors

    Locked

  2. Angel

    Feb 4, 2021

    Amount

    Undisclosed

    Investors

    Locked

Questions about Hexin Med

Who invested in Hexin Med?

Hexin Med has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Hexin Med raised?

Hexin Med has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Hexin Med last raise money?

Hexin Med's most recent round on record is a Series A, in Mar 2023.

What does Hexin Med do?

Founded in 2020 and based in Suzhou, China, Hexin Med operates as a targeted drug provider, specializing in the development of targeted therapeutic integrated nucleotide drugs.

Where is Hexin Med headquartered?

Hexin Med is headquartered in Suzhou, China.

Which VCs invest in companies like Hexin Med?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Hexin Med's stage. Their profiles are linked below.

Raising like Hexin Med? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.